NHS England announces large-scale trial of potential early cancer test. More than 100,000 volunteers are being sought to provide blood samples at mobile test clinics in regions across England, to assess how well the test works in the health service. Participants will be asked to give a first blood sample at a mobile test clinic, and further samples one and two years later.
A new way to deliver clinical trialsWatch the video
"Using mobile units for the NHS-Galleri trial is important for two reasons. The first is that we want to be able to access as many people as possible in the population. By using mobile units, we can go to locations that are easier for volunteers to get to. Second, we didn’t want to increase the burden on the NHS. The mobile units give us an opportunity to undertake the study in all the ways we need to, without adding more pressure on the NHS."
The world’s largest trial of a revolutionary new blood test, the NHS-Galleri Trial, will be conducted on board EMS mobile healthcare spaces as part of a three year study. With the aim of reaching 140,000 volunteers in England aged 50-77, the EMS Group's mobile units and logistical expertise will ensure the trial is conducted in the most accessible locations.
Not only does this decentralised approach improve participant convenience and experience, it also alleviates pressure on primary care settings - where space and capacity is often at a premium. As the future of clinical research moves towards decentralised and hybrid clinical studies, all eyes will be on the NHS-Galleri trial.Contact the EMS Healthcare Team
The world’s largest trial of a revolutionary new blood test that can detect more than 50 types of cancer before symptoms appear has launched this week. The Galleri test checks for the earliest signs of cancer in the blood. The first people to take part will have samples taken at mobile testing clinics in retail parks and other convenient community locations.
The NHS is launching the world's biggest trial of a potentially life-saving blood test that can detect over 50 types of cancer before symptoms appear. It has been especially effective at finding cancers that are more difficult to identify, such as head and neck, bowel, lung, pancreatic and throat, with the potential to save thousands of lives every year.